TB Research

Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis

Sharenja Ratnakumar, S E Hayward, Emma Denneny, Lucy Goldsmith, Rebecca Evans, William Checkley, Delia Goletti, Ong C, et al. (12 authors)

The Lancet Global Health · 2025-05

Abstract

<h2>Summary</h2><h3>Background</h3> Although post-tuberculosis lung disease poses a substantial threat to individuals who have recovered from pulmonary tuberculosis, data showing objective functional impairment in such people are scarce. We did a systematic review and meta-analysis to estimate respiratory impairment after pulmonary tuberculosis disease and examine differences in ventilatory defects. <h3>Methods</h3> We systematically searched Embase, MEDLINE, and CINAHL from Jan 1, 2000, to Dec 13, 2024. We included any study design with data on lung function tests in individuals with a previous diagnosis of pulmonary tuberculosis versus healthy controls. Outcomes extracted from eligible studies included forced expiratory volume in 1 s (FEV<sub>1</sub>), forced vital capacity (FVC), FEV<sub>1</sub> as a percentage of the predicted value (FEV<sub>1</sub>%), FVC as a percentage of the predicted value (FVC%), and FEV<sub>1</sub>/FVC ratio. Pre-bronchodilator values were preferentially selected. Random effects mean difference models were used when possible and standardised mean difference where it was necessary to standardise to a single scale (ie, FEV<sub>1</sub>%, FVC%, and FEV<sub>1</sub>/FVC ratio). Between-study heterogeneity was estimated with <i>I</i><sup>2</sup>. This study was prospectively registered with PROSPERO (CRD42021248838). <h3>Findings</h3> Of the 5594 publications found, data from 19 studies were included for meta-analyses, reporting on 75 960 individuals of whom 7447 had past pulmonary tuberculosis. All studies reporting absolute values, using various levels of adjustment or standardisation, showed that previous pulmonary tuberculosis had a negative effect across all spirometric values: FEV<sub>1</sub> –0·41 L (95% CI –0·51 to –0·32, <i>I</i><sup>2</sup>=90·4%), FVC –0·25 L (–0·33 to –0·17, <i>I</i><sup>2</sup>=80·6%), and FEV<sub>1</sub>/FVC ratio –0·37 (–0·54 to –0·19, <i>I</i><sup>2</sup>=92·0%). In those studies, using reference values to derive FEV<sub>1</sub>% and FVC %, prior pulmonary tuberculosis had a pooled standardised mean difference of –0·44 (–0·60 to –0·28, <i>I</i><sup>2</sup>=95·6%) and –0·33 (–0·54 to –0·13, <i>I</i><sup>2</sup>=91·3%), respectively, compared with controls. <h3>Interpretation</h3> People who recover from pulmonary tuberculosis have significantly decreased lung function compared with controls, with FEV<sub>1</sub> more affected than FVC, giving a mixed obstructive and restrictive picture with predominantly airflow obstruction. <h3>Funding</h3> Breathing Matters.

MeSH terms

  • Meta-analysis
  • Tuberculosis
  • Medicine
  • Lung function
  • Pulmonary tuberculosis
  • Systematic review
  • MEDLINE
  • Lung
  • Intensive care medicine